6Therasse P, Arbuck S G, Eisenhauer E A, et al. New guidelines to evaluate the response to treatment in solid tumors[J]. J Natl Cancer Inst, 2000, 92(3): 205- 216.
7Thatcher N,Chang A,Parikh P,et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non small cell lung cancer: results from a randomized, placebo controlled multicenter study (lressa survival Evaluation in Lung Cancer)[J]. Lancet,2005,366(9496): 1527- 1537.
8Shepherd F A,Pereira J R,Ciuleanu T,et ah Erlotinib in previously treated non small cell lung cancer[J]. N Engl J Med, 2005,353(2):123- 132.
9Hanagiri T,Sugio K, Uramoto H,et al. Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer[J]. Surg Today,2007,37(7)546- 551.
10Pujol J L, Breton J L,Gervais R, et al. Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to ehemotherapy[J].Clin Oncol,2007,25(25) : 3945 3951.
